Panel finds efficacy for Regeneron’s REGEN-COV in Phase III Covid-19 trial
Regeneron Pharmaceuticals has announced that Independent Data Monitoring Committee (IDMC) found its REGEN-COV antibody cocktail to have clear clinical efficacy…
25 Feb 2021
Bayer reports steady 2020 performance despite Covid-19 pandemic
German-headquartered pharma company Bayer has published its 2020 annual report. The report suggests that Bayer had a robust 2020 despite the Covid-19 pandemic and there was positive momentum for solid…
25 Feb 2021
EMA begins review of Celltrion’s antibody data for Covid-19 treatment
The human medicines committee (CHMP) of the European Medicines Agency (EMA) has initiated a rolling review of data on Celltrion’s monoclonal antibody regdanvimab (CT-P59) for Covid-19 treatment. Regdanvimab works against…
25 Feb 2021
Egyptian Drug Authority approves Sputnik V vaccine for emergency use
The Egyptian Drug Authority has approved the Russian Direct Investment Fund’s (RDIF) Covid-19 vaccine, Sputnik V, under the emergency use authorisation (EUA) procedure. The vaccine derives from a human adenoviral…
25 Feb 2021
FDA finds J&J’s single-dose Covid-19 vaccine safe and effective in trials
The US Food and Drug Administration (FDA) said that Johnson & Johnson’s single-shot Covid-19 vaccine, Ad26.COV2.S is safe and effective, according to the data submitted from its ongoing Phase III…
24 Feb 2021
UCB and Microsoft expand drug development partnership
UCB and Microsoft have entered into a new multi-year, strategic collaboration. The collaboration will merge Microsoft’s computational services, Cloud and artificial intelligence (AI) with UCB’s drug discovery and development capabilities.…
24 Feb 2021
CDC adds cetirizine as therapy for anaphylaxis after Covid-19 vaccination
TerSera Therapeutics has announced the addition of cetirizine as adjunctive therapy to the Centers for Disease Control and Prevention (CDC) guidelines titled ‘Interim considerations: preparing for the potential management of…